These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 3092654)

  • 1. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
    Thomas FJ; Koss MA; Hogan DL; Isenberg JI
    Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisecretory and serum gastrin lowering effect of enprostil in patients with duodenal ulcer disease.
    Mahachai V; Walker K; Sevelius H; Thomson AB
    Gastroenterology; 1985 Sep; 89(3):555-61. PubMed ID: 3926591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic interaction between an H2-receptor antagonist and enprostil on 24-hour intragastric pH, serum gastrin concentration, and tissue immunoperoxidase staining for gastrin, somatostatin, and serotonin in a patient with metastatic gastrinoma.
    Sherbaniuk R; Jewell LD; Yacoub W; Pinchbeck B; Salkie ML; Walker K; Mahachai V; Kirdeikis P; Zuk L; Brunet MK
    Clin Ther; 1986; 8(6):667-88. PubMed ID: 2878726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory action of enprostil (4,5-dehydro-16-phenoxy-17,18,19,20-tetranor-PGE2) on tetra-gastrin stimulated acid secretion in human subjects.
    Moriga M; Aono M; Narusawa H; Kohli Y; Kato T; Kajiyama G; Inoue M; Miyoshi A
    Gastroenterol Jpn; 1989 Apr; 24(2):115-9. PubMed ID: 2501133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of orally administered 15(R)-15-methyl prostaglandin E2 and/or an anticholinergic drug on meal-induced gastric acid secretion and serum gastrin level in patients with duodenal ulcers.
    Konturek SJ; Swierczek JS; Kwiecien N; Obtułowicz W; Sito E; Oleksy J
    Scand J Gastroenterol; 1979; 14(7):813-9. PubMed ID: 395627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a single oral dose of enprostil on gastric secretion and gastrin release. Studies in healthy volunteers and patients with pernicious anemia.
    Buchanan N; Laferla G; Hearns J; Buchanan KD; Crean GP; McColl KE
    Am J Med; 1986 Aug; 81(2A):40-3. PubMed ID: 3092653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 11R, 16, 16-trimethyl prostaglandin E2 on meal-stimulated gastric acid secretion in duodenal ulcer subjects.
    Lenz HJ; Brozinsky S; Koss MA; Hogan DL; Scheinbaum ML; Isenberg JI
    Eur J Clin Pharmacol; 1986; 31(3):281-4. PubMed ID: 3792425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of enprostil, a synthetic prostaglandin E2 on 24 hour intragastric acidity, nocturnal acid and pepsin secretion.
    Deakin M; Ramage J; Paul A; Gray SP; Billings J; Williams JG
    Gut; 1986 Sep; 27(9):1054-7. PubMed ID: 3093317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of two-week treatment with enprostil (35 micrograms twice a day) on 24-hour serum gastrin levels.
    Florent C; Cogoni C; Joubert M; Desaint B
    Dig Dis Sci; 1990 Nov; 35(11):1352-7. PubMed ID: 2121423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synthetic prostaglandin E2 analogue, enprostil, hastens gastric emptying of solids in patients with an active duodenal ulcer.
    Nowak A; Jonderko K; Nowakowska-Duława E; Adamczak D; Rudzka J; Nowak S
    Scand J Gastroenterol; 1990 Nov; 25(11):1118-22. PubMed ID: 2125742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of the gastric acid and serum gastrin-lowering effects of the prostaglandin E2 analog enprostil.
    Baak LC; Jansen JB; Meijer JL; Lamers CB
    Clin Pharmacol Ther; 1993 Jun; 53(6):668-4. PubMed ID: 8513659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enprostil reduces G-cell hyperplasia and hypergastrinemia in duodenal ulcer.
    Jewell LD; Yacoub W; Salkie ML; Sherbaniuk R; Walker K; Mahachai V; Kirdeikis P; Simpson I; Zuk L; Brunet MK
    Clin Ther; 1987; 9(3):281-95. PubMed ID: 3111703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.
    Goa KL; Monk JP
    Drugs; 1987 Nov; 34(5):539-59. PubMed ID: 3121276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of enprostil on basal and meal-stimulated gastric acid and pepsin secretion, serum gastrin and gastric emptying in healthy persons.
    Berstad K; Massey H; Berstad A
    Aliment Pharmacol Ther; 1988 Feb; 2(1):65-72. PubMed ID: 2979235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enprostil reduces the increase of gastric corpus mucosal mass induced by the hydrogen-potassium-stimulated adenosine triphosphatase inhibitor BY 831-78 in the rat.
    Inauen W; Rohner C; Koelz HR; Herdmann J; Schürer-Maly CC; Varga L; Halter F
    Gastroenterology; 1989 Oct; 97(4):846-52. PubMed ID: 2570729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients.
    Ippoliti AF; Isenberg JI; Hagie L
    Gastroenterology; 1981 Jan; 80(1):55-9. PubMed ID: 7450412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of 16,16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in duodenal ulcer patients.
    Ippoliti AF; Isenberg JI; Maxwell V; Walsh JH
    Gastroenterology; 1976 Apr; 70(4):488-91. PubMed ID: 1254135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variations of plasma gastrin (basal and postprandial) in ththtreatmentof duodenal ulcer with either enprostil or ranitidine. Correlations with rates of relapse].
    Bado A; Corrion F; Bernades P; Chevalier T; Galmiche JP; Laverdant C; Mignon M; Minaire Y; Pariente A; Vicari F
    Gastroenterol Clin Biol; 1994; 18(6-7):623-9. PubMed ID: 7875420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four-hour intragastric acidity and clinical trial of bedtime enprostil 70 micrograms compared with ranitidine 300 mg in duodenal ulcer.
    Walt RP; Pounder RE; Hawkey CJ; Santana IA; Somerville KW; Logan RF; Long RG; Langman MJ
    Aliment Pharmacol Ther; 1987 Apr; 1(2):161-6. PubMed ID: 2979218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of duodenal ulcer with enprostil, a prostaglandin E2 analogue.
    Bright-Asare P
    Am J Med; 1986 Aug; 81(2A):64-8. PubMed ID: 3092658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.